156 related articles for article (PubMed ID: 7251327)
1. Urinary diversion and systemic chemotherapy in the treatment of experimental early neoplastic lesions of the bladder.
Rowland RG; Wearly DW
Invest Urol; 1981 Jul; 19(1):49-51. PubMed ID: 7251327
[TBL] [Abstract][Full Text] [Related]
2. Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions.
Rowland RG; Henneberry MO; Oyasu R; Grayhack JT
Cancer Res; 1980 Dec; 40(12):4524-7. PubMed ID: 7438086
[TBL] [Abstract][Full Text] [Related]
3. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
Grossman HB; Sonda LP; Lesser ML
Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
[TBL] [Abstract][Full Text] [Related]
4. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Fukushima S; Friedell GH; Jacobs JB; Cohen SM
Cancer Res; 1981 Aug; 41(8):3100-3. PubMed ID: 7248968
[TBL] [Abstract][Full Text] [Related]
5. Studies of experimental bladder carcinoma in Fischer 344 female rats. I. Induction of tumors with diet low in vitamin B6 containing N-2-fluorenylacetamide after single dose of cyclophosphamide.
Koss LG; Lavin P
J Natl Cancer Inst; 1971 Mar; 46(3):585-95. PubMed ID: 5547314
[No Abstract] [Full Text] [Related]
6. Early lesions in experimental bladder cancer: experimental design and light microscopic findings.
Cohen SM; Jacobs JB; Arai M; Johansson S; Friedell GH
Cancer Res; 1976 Jul; 36(7 PT 2):2508-11. PubMed ID: 1277158
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructure and reversibility of bladder carcinoma of rats produced by feeding of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
Pai SH; Amaral L; Werthamer S; Zak FG
Invest Urol; 1973 Sep; 11(2):125-35. PubMed ID: 4728260
[No Abstract] [Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
9. The production of carcinoma of the urinary bladder in rats by feeding N-[3-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Ertürk E; Price JM; Morris JE; Cohen S; Leith RS; Von Esch AM; Crovetti AJ
Cancer Res; 1967 Nov; 27(11):1998-2002. PubMed ID: 6073497
[No Abstract] [Full Text] [Related]
10. [Epithelial bladder tumor induction in rats with N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide].
Vlasov NN; Pliss GB; Balin VV
Vopr Onkol; 1980; 26(3):63-7. PubMed ID: 7368659
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
12. Malignant transformation of urinary bladder in humans and in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-exposed Fischer rats: ultrastructure of the major components of the permeability barrier.
Merk FB; Pauli BU; Jacobs JB; Alroy J; Friedell GH; Weinstein RS
Cancer Res; 1977 Aug; 37(8 Pt 2):2843-53. PubMed ID: 872113
[No Abstract] [Full Text] [Related]
13. Temporal comparisons of immune status and target organ histology in mice fed carcinogenic 5-nitrofurans and their nornitro analogs.
Headley DB; Klopp RG; Michie PM; Ertürk E; Bryan GT
Cancer Res; 1981 Apr; 41(4):1397-1401. PubMed ID: 7214326
[No Abstract] [Full Text] [Related]
14. Early lesions in experimental bladder cancer: scanning electron microscopy of cell surface markers.
Jacobs JB; Arai M; Cohen SM; Friedell GH
Cancer Res; 1976 Jul; 36(7 PT 2):2512-7. PubMed ID: 1277159
[TBL] [Abstract][Full Text] [Related]
15. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
16. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
Cohen SM; Zenser TV; Murasaki G; Fukushima S; Mattammal MB; Rapp NS; Davis BB
Cancer Res; 1981 Sep; 41(9 Pt 1):3355-9. PubMed ID: 6790163
[TBL] [Abstract][Full Text] [Related]
17. Effect of regenerative hyperplasia on the urinary bladder: carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Cohen SM; Murasaki G; Fukushima S; Greenfield RE
Cancer Res; 1982 Jan; 42(1):65-71. PubMed ID: 7053869
[No Abstract] [Full Text] [Related]
18. Carcinogenic action of low-dose cyclophosphamide given orally to Sprague-Dawley rats in a lifetime experiment.
Schmähl D; Habs M
Int J Cancer; 1979 May; 23(5):706-12. PubMed ID: 572348
[No Abstract] [Full Text] [Related]
19. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
[TBL] [Abstract][Full Text] [Related]
20. Effect of intralesional and systemic BCG-application or a combined cyclophosphamide/BCG treatment on experimental bladder cancer.
Adolphs HD; Thiele J; Kiel H
Urol Res; 1979 Jun; 7(2):71-8. PubMed ID: 473445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
